21 CFR Part 312, Subpart D - Responsibilities of Sponsors and Investigators
- § 312.50 — General responsibilities of sponsors.
- § 312.52 — Transfer of obligations to a contract research organization.
- § 312.53 — Selecting investigators and monitors.
- § 312.54 — Emergency research under § 50.24 of this chapter.
- § 312.55 — Informing investigators.
- § 312.56 — Review of ongoing investigations.
- § 312.57 — Recordkeeping and record retention.
- § 312.58 — Inspection of sponsor's records and reports.
- § 312.59 — Disposition of unused supply of investigational drug.
- § 312.60 — General responsibilities of investigators.
- § 312.61 — Control of the investigational drug.
- § 312.62 — Investigator recordkeeping and record retention.
- § 312.64 — Investigator reports.
- § 312.66 — Assurance of IRB review.
- § 312.68 — Inspection of investigator's records and reports.
- § 312.69 — Handling of controlled substances.
- § 312.70 — Disqualification of a clinical investigator.
Title 21 published on 2015-04-01.
The following are only the Rules published in the Federal Register after the published date of Title 21.
For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.
Title 21 published on 2015-04-01
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 312 after this date.